Pediatricians do not always feel comfortable or sufficiently trained to tackle the increasing growth in ADHD patient numbers

Attention Deficit Hyperactivity Disorder (ADHD) is a neurobehavioral disorder that affects 3-5 percent of all American children. Today pediatricians appear to be treating more children with these behavioral health problems. However, a new study from Wake Forest University Baptist Medical Center suggests that they do not always feel comfortable or sufficiently trained to tackle the increasing growth in patient numbers.

The study involved interviews with community pediatricians who estimated that an average of about 15 percent of the children they see have behavioral health problems, said Jane Williams, Ph.D., lead author of the study. The report was published in the September issue of Pediatrics.

Attention Deficit Hyperactivity Disorder (ADHD) is the most common behavioral health disorder seen by pediatricians, she said. The pediatricians "expressed a high level of comfort with the diagnosis and frequently or occasionally prescribed stimulants" to treat it.

But when a child is suffering from anxiety or depression, the pediatricians felt they were on shakier grounds. Fewer than half the pediatricians said they diagnosed anxiety and depression frequently. Those that did typically used questionnaires in making the diagnosis and prescribed drugs from a class that includes Prozac, Zoloft and Paxil.

The study found a "strong interest in diagnosing and treating behavioral health disorders within their perceived limits and level of comfort," Williams and her Wake Forest Baptist colleagues reported. "They were very concerned about the correctness of these diagnoses and consider the impact on both the child and family."

The researchers said pediatricians are treating more children with psychiatric problems in part because of chronic underfunding of the public mental health system. Only about 2 percent of the children who need treatment are seen by mental health specialists.

In fact, the diagnosis and treatment of ADHD has shifted primarily to pediatricians, the results showed. "The diagnosis of anxiety and depression appeared to be shifting more gradually to pediatric providers," Williams said.

But many pediatricians felt they were not prepared in medical school and their residency training programs to treat these children, leading to a scramble to find continuing medical education courses to fill that gap. They often felt unprepared to treat depression and anxiety and to choose appropriate drugs for these diagnoses.

"Perhaps the most important and most generalizable findings of this study involve the need for increased training and for continuing medical education in behavioral health," Williams said.

That's of special concern because depression often leads to both suicide and substance abuse. "As primary care settings may be the only environment in which adolescents are seen, their high mortality rate from accidents, homicide and suicide would suggest the critical need for pediatricians to recognize and inquire about these symptoms," she said.

ADHD interferes with a person’s ability to stay on a task and to exercise age-appropriate inhibition (cognitive alone or both cognitive and behavioral). ADHD is usually diagnosed in childhood, although the condition can continue into the adult years.

Treatments for ADHD may also include medications such as methylphenidate (Ritalin), dextroamphetamine (Dexedrine) or pemoline (Cylert), which are stimulants that decrease impulsivity and hyperactivity and increase attention.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Why children with Down’s syndrome are predisposed to developing leukaemia